Get started
Guardant Health, Inc.Guardant Health, Inc.Guardant Health, Inc.

Guardant Health, Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

GH chart


Full chart

GH upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪3.90 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.24 USD
Net income (FY)
‪−479.45 M‬ USD
Revenue (FY)
‪563.95 M‬ USD
Shares float
‪117.85 M‬
Beta (1Y)
2.03

Employees


Employees (FY)
‪1.78 K‬
Change (1Y)
−14 −0.78%
Revenue / Employee (1Y)
‪317.00 K‬ USD
Net income / Employee (1Y)
‪−269.50 K‬ USD

About Guardant Health, Inc.


Sector
Health Services
Industry
Medical/Nursing Services
Headquarters
Palo Alto
Website
guardanthealth.com
Founded
2011
FIGI
BBG006D97VY9
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GH news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

GH highest yielding bonds


GH5313849
Guardant Health, Inc. 0.0% 15-NOV-2027
Yield to maturity
6.63%
Maturity date
Nov 15, 2027

Explore more bonds 

Sparks


Curated watchlists where GH is featured.

See all sparks 

Frequently Asked Questions


The current price of GH is 31.57 USD — it has increased by 1.71% in the past 24 hours. Watch Guardant Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Guardant Health, Inc. stocks are traded under the ticker GH.
GH stock has fallen by −9.95% compared to the previous week, the month change is a 1.28% rise, over the last year Guardant Health, Inc. has showed a 14.72% increase.
We've gathered analysts' opinions on Guardant Health, Inc. future price: according to them, GH price has a max estimate of 60.00 USD and a min estimate of 19.00 USD. Watch GH chart and read a more detailed Guardant Health, Inc. stock forecast: see what analysts think of Guardant Health, Inc. and suggest that you do with its stocks.
GH reached its all-time high on Feb 12, 2021 with the price of 181.07 USD, and its all-time low was 15.81 USD and was reached on Apr 19, 2024. View more price dynamics on GH chart.
See other stocks reaching their highest and lowest prices.
GH stock is 3.12% volatile and has beta coefficient of 2.03. Track Guardant Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Guardant Health, Inc. there?
Today Guardant Health, Inc. has the market capitalization of ‪3.90 B‬, it has decreased by −10.91% over the last week.
Yes, you can track Guardant Health, Inc. financials in yearly and quarterly reports right on TradingView.
Guardant Health, Inc. is going to release the next earnings report on Feb 20, 2025. Keep track of upcoming events with our Earnings Calendar.
GH earnings for the last quarter are −0.88 USD per share, whereas the estimation was −0.73 USD resulting in a −20.48% surprise. The estimated earnings for the next quarter are −0.78 USD per share. See more details about Guardant Health, Inc. earnings.
Guardant Health, Inc. revenue for the last quarter amounts to ‪191.48 M‬ USD, despite the estimated figure of ‪170.49 M‬ USD. In the next quarter, revenue is expected to reach ‪186.78 M‬ USD.
GH net income for the last quarter is ‪−107.75 M‬ USD, while the quarter before that showed ‪−102.63 M‬ USD of net income which accounts for −4.99% change. Track more Guardant Health, Inc. financial stats to get the full picture.
No, GH doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has ‪1.78 K‬ employees. See our rating of the largest employees — is Guardant Health, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Guardant Health, Inc. EBITDA is ‪−471.93 M‬ USD, and current EBITDA margin is −92.14%. See more stats in Guardant Health, Inc. financial statements.
Like other stocks, GH shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Guardant Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Guardant Health, Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Guardant Health, Inc. stock shows the neutral signal. See more of Guardant Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.